Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type-2-diabetes Mellitus”

11,317 trials

Showing 20 of 11,317 results

Post-approval studies (Phase 4)Looking for participantsNCT06291155
What this trial is testing

Mechanism of SGLT2 Inhibition in the Kidney

Who this might be right for
Type 2 DiabetesDiabetic Kidney Disease
University of Michigan 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT06866158
What this trial is testing

Autologous Dendritic Cell as Adjunct Therapy for Diabetic Kidney Disease

Who this might be right for
Diabetic Kidney Disease (DKD)
PT. JES Kasih Nusantara Sejahterah 80
Not applicableStudy completedNCT05822648
What this trial is testing

Evaluating a Type 2 Diabetes Prevention Program

Who this might be right for
Type 2 DiabetesPreDiabetes
Stanford University 62
Not applicableStudy completedNCT06187285
What this trial is testing

Efficay and Safety of Empagliflozin Versus Sitagliptin for the In-patient Management of Hyperglycemia

Who this might be right for
Type 2 Diabetes
Medanta, The Medicity, India 220
Not applicableStudy completedNCT05742685
What this trial is testing

Refinement and Adaption of Reinforcement Learning to Personalize Behavioral Messaging for Healthy Habits

Who this might be right for
Diabetes Mellitus, Type 2Medication Adherence
Brigham and Women's Hospital 28
Large-scale testing (Phase 3)Study completedNCT00325117
What this trial is testing

To Assess the Efficacy and Safety of Vildagliptin as Add-on Therapy to Sulfonylurea in Patients With Type 2 Diabetes Inadequately Controlled With Sulfonylurea Monotherapy

Who this might be right for
Diabetes Mellitus, Type 2
Novartis 200
Not applicableStudy completedNCT07269197
What this trial is testing

Association of SGLT2 Inhibitors Therapy With Elastographic and Molecular Markers of Liver Injury in Type 2 Diabetes

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseDiabetes Mellitus, Type 2
Josip Juraj Strossmayer University of Osijek 67
Post-approval studies (Phase 4)UnknownNCT04027023
What this trial is testing

Evaluation of the Impact of Intensive Short-Term Drug Therapy in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Sciema UG 9
Testing effectiveness (Phase 2)Study completedNCT01030679
What this trial is testing

Evaluate the Glycemic Control of CKD-501 in Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Chong Kun Dang Pharmaceutical 214
Early research (Phase 1)Study completedNCT01054118
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Doses of JNJ-38431055, Sitagliptin, and Co-administration of JNJ-38431055 and Sitagliptin

Who this might be right for
Diabetes Mellitus, Type 2
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 18
Not applicableUnknownNCT01178723
What this trial is testing

The Effects of Breakfast Size on Hormonal Profile in Adults With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Wolfson Medical Center 48
Not applicableUnknownNCT00145288
What this trial is testing

Prospective Study of Patients With Hirsutism

Who this might be right for
HirsutismType 2 DiabetesPolycystic Ovary Syndrome
Odense University Hospital 340
Not applicableLooking for participantsNCT05933161
What this trial is testing

Glycemic Control in Left Ventricular Assist

Who this might be right for
Type 2 Diabetes MellitusHyperglycemiaHypoglycemia
Mayo Clinic 20
Large-scale testing (Phase 3)Study completedNCT01871558
What this trial is testing

Vildagliptin/Metformin in T2DM Patients Starting Basal Insulin

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Novartis Pharmaceuticals 42
Not applicableStudy completedNCT01542476
What this trial is testing

The Impact of Initiating/Switching to Insulin Detemir on Emotional Well-being and Treatment Satisfaction

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 299
Testing effectiveness (Phase 2)Study completedNCT00660374
What this trial is testing

Safety and Efficacy of Insulin NPH Compared to a New Insulin Formulation in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 402
Not applicableLooking for participantsNCT06730113
What this trial is testing

Youth-Onset Type 2 Diabetes and Heart Disease: The Young at Heart Prospective Cohort Study

Who this might be right for
ObesityType 2 Diabetes
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 930
Post-approval studies (Phase 4)UnknownNCT04120623
What this trial is testing

Therapeutic Effect of Dapagliflozin Combined With CSII on Newly Diagnosed Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Nanjing First Hospital, Nanjing Medical University 100
Not applicableStudy completedNCT03210896
What this trial is testing

Breath for Better Health Study

Who this might be right for
Type2 Diabetes
University Hospitals Coventry and Warwickshire NHS Trust 175
Post-approval studies (Phase 4)Study completedNCT02040246
What this trial is testing

Comparison of Metformin and Repaglinide Monotherapy in the Treatment of New Onset Type 2 Diabetes Mellitus in China

Who this might be right for
Diabetes Mellitus, Type 2
RenJi Hospital 107
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation